Information Provided By:
Fly News Breaks for July 1, 2015
ONTX
Jul 1, 2015 | 06:44 EDT
Piper Jaffray analyst Charles Duncan upgraded Onconova Therapeutics to Overweight and doubled his price target for shares to $6 from $3. Following yesterday's analyst day, Duncan has increased visibility on the company's plans for rigosertib in higher-risk Myelodysplastic syndromes. Upcoming catalysts include enrollment and data updates from INSPIRE, the analyst tells investors this morning in a research note. Shares of Onconova closed yesterday at $2.37.
News For ONTX From the Last 2 Days
There are no results for your query ONTX